TY - JOUR
T1 - Early emergence of ganciclovir-resistant human cytomegalovirus strains in children with primary combined immunodeficiency
AU - Wolf, Dana G.
AU - Yaniv, Isaac
AU - Honigman, Alik
AU - Kassis, Imad
AU - Schonfeld, Tommy
AU - Ashkenazi, Shai
N1 - Funding Information:
Received 29 December 1997; revised 17 March 1998. Financial support: Israel Cancer Research Foundation; Israel Ministry of Health. Reprints or correspondence: Dr. Dana G. Wolf, Dept. of Clinical Microbiology and Infectious Diseases, Hadassah University Hospital, Jerusalem 91120, Israel.
PY - 1998
Y1 - 1998
N2 - Children with primary combined immunodeficiency (CID) and human cytomegalovirus-(HCMV) infection often deteriorate despite antiviral therapy. In this study, the emergence of ganciclovir-resistant strains was examined in 6 children with CID and HCMV infection, using sequence analysis of the HCMV UL97 gene and virus susceptibility assays. Mutations in the proposed ATP. binding site associated with ganciclovir resistance were found in 4 of the 6 children. In 1 patient with B- severe CID, an unusual multiplicity of mutations was found in the UL97 substrate binding domain between aa 590-606. All mutations were detected within 10 days to 3 weeks from initiation of therapy. The emergence of resistant strains in children with CID appears earlier than in other groups of HCMV-infected patients. These findings may have relevance to the cellular pathways involved in viral DNA repair and mutagenesis, and they indicate the need for early and frequent genotypic monitoring and prompt therapeutic modification in this patient population.
AB - Children with primary combined immunodeficiency (CID) and human cytomegalovirus-(HCMV) infection often deteriorate despite antiviral therapy. In this study, the emergence of ganciclovir-resistant strains was examined in 6 children with CID and HCMV infection, using sequence analysis of the HCMV UL97 gene and virus susceptibility assays. Mutations in the proposed ATP. binding site associated with ganciclovir resistance were found in 4 of the 6 children. In 1 patient with B- severe CID, an unusual multiplicity of mutations was found in the UL97 substrate binding domain between aa 590-606. All mutations were detected within 10 days to 3 weeks from initiation of therapy. The emergence of resistant strains in children with CID appears earlier than in other groups of HCMV-infected patients. These findings may have relevance to the cellular pathways involved in viral DNA repair and mutagenesis, and they indicate the need for early and frequent genotypic monitoring and prompt therapeutic modification in this patient population.
UR - http://www.scopus.com/inward/record.url?scp=0031848922&partnerID=8YFLogxK
U2 - 10.1086/517468
DO - 10.1086/517468
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 9697738
AN - SCOPUS:0031848922
SN - 0022-1899
VL - 178
SP - 535
EP - 538
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 2
ER -